Clinical Trials Logo

Clinical Trial Summary

This study compares the efficacy of a single intra-operative (intravenous) dose of "cephalexin" (first generation cephalosporin) or "clindamycin" (lincosamides), alone versus both intra-operative (intravenous) dose of "cephalexin" (first generation cephalosporin) or "clindamycin" (lincosamides) and postoperative oral dose of "cephalexin" or "clindamycin" use in nasal surgery.


Clinical Trial Description

The study will consist of 2 treatment arms: Treatment arm A: Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or "clindamycin" 900 mg. Treatment arm B: Intra-operative single intravenous(iv) dose of "cephalexin" 2 g or "clindamycin" 900 mg and postoperative oral dose of "cephalexin" 250mg every 4 hours or "clindamycin" 150mg every 6 hours, for a duration of three days. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04194216
Study type Interventional
Source Stanford University
Contact
Status Enrolling by invitation
Phase Phase 3
Start date May 20, 2020
Completion date April 20, 2025

See also
  Status Clinical Trial Phase
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Recruiting NCT04228016 - Efficacy of an Intranasal Stent on Nasal Obstruction at Night N/A
Completed NCT02914236 - Treatment of Nasal Airway Obstruction Using the Aerin Medical Device N/A
Completed NCT02952313 - Spirox Lateraâ„¢ Implant Support of Lateral Nasal Wall Cartilage (LATERAL-OR) Study N/A
Completed NCT01965457 - Assessment of Adenoidal Obstruction in Children : Clinical Signs Versus Flexible Nasal Endoscopy and Roentgenographic Findings N/A
Completed NCT00850876 - Heated Humidified Continuous Positive Airway Pressure and Nasal Physiology N/A
Completed NCT03156270 - Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction N/A
Active, not recruiting NCT05099263 - The Vivaer Procedure for Treatment of the Septal Swell Bodies (SWELL) N/A
Recruiting NCT05573919 - VivAer: A Correlation Between Symptom Scores and Objective Findings N/A
Completed NCT03290300 - Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
Recruiting NCT04499469 - The Role of Spreader Grafts in Reduction Rhinoseptoplasty: a Randomized Clinical Trial With Quality of Life Assessment N/A
Not yet recruiting NCT01702103 - Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays Phase 3
Completed NCT04220853 - Changes in Nasal Airflow Parameters After Septoplasty and Turbinoplasty N/A
Completed NCT03456115 - A New Treatment for Mechanical Nasal Obstruction N/A
Completed NCT00793117 - The Effect of Packing in Post Operative Management of FESS Phase 4
Completed NCT02964312 - LATERA-OFFICE Study N/A
Recruiting NCT04150783 - Computational Modeling of Cleft Lip Nasal Deformity and Assessment of Nasal Function and Treatment Outcomes
Completed NCT01506583 - Clinical Evaluation of QFlu Combo Test
Recruiting NCT03925389 - Outcome Analysis in Septorhinoplasty
Recruiting NCT05494346 - Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction N/A